Long-term safety study of a new schizophrenia medication

This is a one-year study testing LB-102, a new medication for schizophrenia, in adults whose current antipsychotic isn't working well enough or is causing side effects they can't tolerate. Researchers want to understand how safe this medication is over a longer period and how well patients handle it. You would be part of a large group of 900 people across multiple sites helping gather this important safety information.

Many people with schizophrenia struggle with their current medications — either because the drugs aren't controlling their symptoms well enough, or because side effects are too bothersome. This study exists to see whether this medication could be a better option for people in that situation, and to make sure it's safe to use over time.